1
|
Takahashi K, Tanabe K, Ohnuki M, Narita M,
Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem
cells from adult human fibroblasts by defined factors. Cell.
131:861–872. 2007.PubMed/NCBI View Article : Google Scholar
|
2
|
Deguchi S, Takayama K and Mizuguchi H:
Generation of human induced pluripotent stem cell-derived
hepatocyte-like cells for cellular medicine. Biol Pharm Bull.
43:608–615. 2020.PubMed/NCBI View Article : Google Scholar
|
3
|
DeLaForest A, Nagaoka M, Si-Tayeb K, Noto
FK, Konopka G, Battle MA and Duncan SA: HNF4A is essential for
specification of hepatic progenitors from human pluripotent stem
cells. Development. 138:4143–4153. 2011.PubMed/NCBI View Article : Google Scholar
|
4
|
Si-Tayeb K, Noto FK, Nagaoka M, Li J,
Battle MA, Duris C, North PE, Dalton S and Duncan SA: Highly
efficient generation of human hepatocyte-like cells from induced
pluripotent stem cells. Hepatology. 51:297–305. 2010.PubMed/NCBI View Article : Google Scholar
|
5
|
Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo
S, Song X, Guo Y, Zhao Y, Qin H, et al: Efficient generation of
hepatocyte-like cells from human induced pluripotent stem cells.
Cell Res. 19:1233–1242. 2009.PubMed/NCBI View Article : Google Scholar
|
6
|
Takayama K, Inamura M, Kawabata K,
Katayama K, Higuchi M, Tashiro K, Nonaka A, Sakurai F, Hayakawa T,
Furue MK and Mizuguchi H: Efficient generation of functional
hepatocytes from human embryonic stem cells and induced pluripotent
stem cells by HNF4α transduction. Mol Ther. 20:127–137.
2012.PubMed/NCBI View Article : Google Scholar
|
7
|
Tashiro K, Kawabata K, Inamura M, Takayama
K, Furukawa N, Sakurai F, Katayama K, Hayakawa T, Furue MK and
Mizuguchi H: Adenovirus vector-mediated efficient transduction into
human embryonic and induced pluripotent stem cells. Cell Reprogram.
12:501–507. 2010.PubMed/NCBI View Article : Google Scholar
|
8
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: Transcription factors and
medium suitable for initiating the differentiation of human-induced
pluripotent stem cells to the hepatocyte lineage. J Cell Biochem.
117:2001–2009. 2016.PubMed/NCBI View Article : Google Scholar
|
9
|
Takebe T, Sekine K, Enomura M, Koike H,
Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, et al:
Vascularized and functional human liver from an iPSC-derived organ
bud transplant. Nature. 499:481–484. 2013.PubMed/NCBI View Article : Google Scholar
|
10
|
Shinozawa T, Kimura M, Cai Y, Saiki N,
Yoneyama Y, Ouchi R, Koike H, Maezawa M, Zhang RR, Dunn A, et al:
High-fidelity drug-induced liver injury screen using human
pluripotent stem cell-derived organoids. Gastroenterology.
160:831–846.e10. 2021.PubMed/NCBI View Article : Google Scholar
|
11
|
Roy-Chowdhury N, Wang X, Guha C and
Roy-Chowdhury J: Hepatocyte-like cells derived from induced
pluripotent stem cells. Hepatol Int. 11:54–69. 2017.PubMed/NCBI View Article : Google Scholar
|
12
|
Olgasi C, Cucci A and Follenzi A:
iPSC-derived liver organoids: A journey from drug screening, to
disease modeling, arriving to regenerative medicine. Int J Mol Sci.
21(6215)2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Finley LWS: What is cancer metabolism?
Cell. 186:1670–1688. 2023.PubMed/NCBI View Article : Google Scholar
|
14
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956.PubMed/NCBI View Article : Google Scholar
|
15
|
Abu Dawud R, Schreiber K, Schomburg D and
Adjaye J: Human embryonic stem cells and embryonal carcinoma cells
have overlapping and distinct metabolic signatures. PLoS One.
7(e39896)2012.PubMed/NCBI View Article : Google Scholar
|
16
|
Wang Y, Lei J, Zhang S, Wang X, Jin J, Liu
Y, Gan M, Yuan Y, Sun L, Li X, et al: 4EBP1 senses extracellular
glucose deprivation and initiates cell death signaling in lung
cancer. Cell Death Dis. 13(1075)2022.PubMed/NCBI View Article : Google Scholar
|
17
|
Adeva-Andany MM, Pérez-Felpete N,
Fernández-Fernández C, Donapetry-García C and Pazos-García C: Liver
glucose metabolism in humans. Biosci Rep. 36(e00416)2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Tomizawa M, Shinozaki F, Sugiyama T,
Yamamoto S, Sueishi M and Yoshida T: Survival of primary human
hepatocytes and death of induced pluripotent stem cells in media
lacking glucose and arginine. PLoS One. 8(e71897)2013.PubMed/NCBI View Article : Google Scholar
|
19
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: An optimal medium
supplementation regimen for initiation of hepatocyte
differentiation in human induced pluripotent stem cells. J Cell
Biochem. 116:1479–1489. 2015.PubMed/NCBI View Article : Google Scholar
|
20
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: Oncostatin M in William's E
medium is suitable for initiation of hepatocyte differentiation in
human induced pluripotent stem cells. Mol Med Rep. 15:3088–3092.
2017.PubMed/NCBI View Article : Google Scholar
|
21
|
Davies B and Fried M: The L19 ribosomal
protein gene (RPL19): Gene organization, chromosomal mapping, and
novel promoter region. Genomics. 25:372–380. 1995.PubMed/NCBI View Article : Google Scholar
|
22
|
Tam S, Clavijo A, Engelhard EK and
Thurmond MC: Fluorescence-based multiplex real-time RT-PCR arrays
for the detection and serotype determination of foot-and-mouth
disease virus. J Virol Methods. 161:183–191. 2009.PubMed/NCBI View Article : Google Scholar
|
23
|
Ordoño J, Pérez-Amodio S, Ball K, Aguirre
A and Engel E: The generation of a lactate-rich environment
stimulates cell cycle progression and modulates gene expression on
neonatal and hiPSC-derived cardiomyocytes. Biomater Adv.
139(213035)2022.PubMed/NCBI View Article : Google Scholar
|
24
|
Chen X, Chen A, Woo TL, Choo ABH, Reuveny
S and Oh SKW: Investigations into the metabolism of two-dimensional
colony and suspended microcarrier cultures of human embryonic stem
cells in serum-free media. Stem Cells Dev. 19:1781–1792.
2010.PubMed/NCBI View Article : Google Scholar
|
25
|
Khan AA, Allemailem KS, Alhumaydhi FA,
Gowder SJT and Rahmani AH: The biochemical and clinical
perspectives of lactate dehydrogenase: An enzyme of active
metabolism. Endocr Metab Immune Disord Drug Targets. 20:855–868.
2020.PubMed/NCBI View Article : Google Scholar
|
26
|
Odenwelder DC, Lu X and Harcum SW: Induced
pluripotent stem cells can utilize lactate as a metabolic substrate
to support proliferation. Biotechnol Prog. 37(e3090)2021.PubMed/NCBI View Article : Google Scholar
|
27
|
Cori CF: The glucose-lactic acid cycle and
gluconeogenesis. Curr Top Cell Regul. 18:377–387. 1981.PubMed/NCBI
|
28
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: 2-Deoxy-D-glucose initiates
hepatocyte differentiation in human induced pluripotent stem cells.
Mol Med Rep. 15:3083–3087. 2017.PubMed/NCBI View Article : Google Scholar
|
29
|
Tomizawa M, Shinozaki F, Motoyoshi Y,
Sugiyama T, Yamamoto S and Ishige N: Differentiation of human
induced pluripotent stem cells in William's E initiation medium
supplemented with 3-bromopyruvate and 2-deoxy-d-glucose. Mol Med
Rep. 15:3719–3723. 2017.PubMed/NCBI View Article : Google Scholar
|
30
|
Sinton MC, Meseguer-Ripolles J,
Lucendo-Villarin B, Wernig-Zorc S, Thomson JP, Carter RN, Lyall MJ,
Walker PD, Thakker A, Meehan RR, et al: A human pluripotent stem
cell model for the analysis of metabolic dysfunction in hepatic
steatosis. iScience. 24(101931)2020.PubMed/NCBI View Article : Google Scholar
|